These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31810310)

  • 41. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of hyaluronic acid sheet for the prevention of postlaminectomy adhesions.
    Kato T; Haro H; Komori H; Shinomiya K
    Spine J; 2005; 5(5):479-88. PubMed ID: 16153573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel Self-assembled, Gel-core Hyaluosomes for Non-invasive Management of Osteoarthritis: In-vitro Optimization, Ex-vivo and In-vivo Permeation.
    El-Refaie WM; Elnaggar YS; El-Massik MA; Abdallah OY
    Pharm Res; 2015 Sep; 32(9):2901-11. PubMed ID: 25777613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined effects of photobiomodulation and alendronate on viability of osteoporotic bone marrow-derived mesenchymal stem cells.
    Fallahnezhad S; Amini A; Hajihossainlou B; Chien S; Dadras S; Rezaei F; Bayat M
    J Photochem Photobiol B; 2018 May; 182():77-84. PubMed ID: 29627514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.
    Ettinger B; San Martin J; Crans G; Pavo I
    J Bone Miner Res; 2004 May; 19(5):745-51. PubMed ID: 15068497
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Cho TH; Kim IS; Lee B; Park SN; Ko JH; Hwang SJ
    Tissue Eng Part A; 2017 Dec; 23(23-24):1343-1360. PubMed ID: 28457207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Development of a novel transdermal delivery system of alendronate, a nitrogen containing bisphosphonate, using a new type of hydrophilic patch and dissolving microneedle arrays].
    Katsumi H
    Yakugaku Zasshi; 2014; 134(3):427-31. PubMed ID: 24584024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
    Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
    Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
    Li X; Ominsky MS; Warmington KS; Niu QT; Asuncion FJ; Barrero M; Dwyer D; Grisanti M; Stolina M; Kostenuik PJ; Simonet WS; Paszty C; Ke HZ
    Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of alendronate and vitamin D₃ on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic women.
    Shapses SA; Kendler DL; Robson R; Hansen KE; Sherrell RM; Field MP; Woolf E; Berd Y; Mantz AM; Santora AC
    J Bone Miner Res; 2011 Aug; 26(8):1836-44. PubMed ID: 21448918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of alendronate on lumbar intervertebral disc degeneration with bone loss in ovariectomized rats.
    Song H; Luo Y; Wang W; Li S; Yang K; Dai M; Shen Y; Zhang Y; Zhang L
    Spine J; 2017 Jul; 17(7):995-1003. PubMed ID: 28288923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transdermal Delivery of Recombinant Human Growth Hormone by Liposomal Gel for Skin Photoaging Therapy.
    Chen J; Hu S; Li J; Xing J; Yang Z; Teng L
    ACS Appl Bio Mater; 2024 May; ():. PubMed ID: 38756018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of topical application of 1% sodium alendronate gel in the surgical treatment of periodontal intrabony defects: A 6-month randomized controlled clinical trial.
    Carvalho Dutra B; Oliveira AMSD; Oliveira PAD; Miranda Cota LO; Silveira JO; Costa FO
    J Periodontol; 2019 Oct; 90(10):1079-1087. PubMed ID: 31071760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined treatment with alendronate and Drynaria rhizome extracts : Effect on fracture healing in osteoporotic rats.
    Chen L; Tao ZS; Chen H; Zhou K; Zhou DS
    Z Gerontol Geriatr; 2018 Dec; 51(8):875-881. PubMed ID: 29043444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin.
    Zhang Y; Xia Q; Li Y; He Z; Li Z; Guo T; Wu Z; Feng N
    Theranostics; 2019; 9(1):48-64. PubMed ID: 30662553
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.
    Iwamoto J; Takeda T; Sato Y; Uzawa M
    Aging Clin Exp Res; 2005 Apr; 17(2):157-63. PubMed ID: 15977465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK₂) in postmenopausal RA patients.
    Suzuki K; Tsuji S; Fukushima Y; Nakase T; Hamada M; Tomita T; Yoshikawa H
    Mod Rheumatol; 2013 May; 23(3):450-5. PubMed ID: 22692649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The antifracture efficacy of alendronate.
    Seeman E
    Int J Clin Pract Suppl; 1999 Apr; 101():40-5. PubMed ID: 12675021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of bone biomechanical properties after bone marrow mesenchymal stem cell or alendronate treatment in an osteoporotic animal model.
    Piao C; Li Z; Ding J; Kong D
    Biomed Tech (Berl); 2019 Dec; 64(6):721-727. PubMed ID: 31116701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.